Supplementary Data S1, S2 from Dual Farnesyl and Geranylgeranyl Transferase Inhibitor Thwarts Mutant KRAS-Driven Patient-Derived Pancreatic Tumors

crossref(2023)

引用 0|浏览9
暂无评分
摘要

Supplementary Figure 1. FGTI-2734 does not induce apoptosis in wild-type RAS human cancer cells and normal cells; Supplementary Figure 2. FGTI-2734 inhibits in vivo growth of PDXs from pancreatic cancer patients.

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要